O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$95.1M
2
+$76.2M
3
+$74M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.1M
5
LLY icon
Eli Lilly
LLY
+$66.8M

Top Sells

1
+$205M
2
+$143M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$49.2M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$487M 5.13%
7,624,900
-770,100
2
$448M 4.71%
5,737,100
-218,500
3
$431M 4.54%
2,876,000
-45,000
4
$423M 4.45%
22,479,700
-1,951,200
5
$422M 4.45%
7,395,700
-52,800
6
$422M 4.44%
1,572,715
+148,000
7
$397M 4.18%
1,526,300
+83,800
8
$378M 3.97%
3,774,077
+108,627
9
$277M 2.92%
3,019,200
-402,200
10
$260M 2.74%
1,870,600
-404,500
11
$217M 2.28%
6,776,100
+112,000
12
$203M 2.14%
1,435,000
+55,000
13
$200M 2.1%
2,755,078
-77,900
14
$192M 2.02%
533,000
+50,000
15
$183M 1.93%
2,541,300
+928,300
16
$177M 1.86%
1,903,300
+557,100
17
$166M 1.75%
2,491,200
+340,200
18
$166M 1.75%
2,421,000
+239,000
19
$149M 1.56%
1,869,400
+1,196,400
20
$146M 1.54%
925,200
+23,644
21
$144M 1.52%
2,696,000
+250,000
22
$144M 1.51%
1,120,000
23
$139M 1.47%
3,495,000
+169,000
24
$139M 1.46%
8,345,110
+99,999
25
$130M 1.36%
1,909,000
+76,000
1
2 3 4 5